Parents of babies who participated in an invasive clinical study report a positive experience: the Glucose in Well Babies (GLOW) study.

What Was Tested

The paper reports a study of GLOW Blend (GHK-Cu + BPC-157 + TB-500), published as an observational study.

There is a paucity of data about normal blood metabolite concentrations in healthy babies, in part because of a reluctance to undertake non-therapeutic invasive testing in newborns.

The Glucose in Well Babies study (GLOW) sought to describe blood glucose, lactate and beta-hydroxybutyrate concentrations in healthy term babies over the first 5 postnatal days.

The researchers also sought to understand both parents' experience of participation in this invasive non-therapeutic study.

Who Took Part

By PubMed's age tags, the people studied were adults, both men and women.

Eligible babies were healthy, term, appropriately grown singletons born in a birthing centre, hospital or home within the greater Hamilton area and then discharged home.

How the Study Was Run

At study completion, both parents were asked to independently complete a questionnaire about their experience.

What Was Measured

PubMed files the paper under topics including 3-Hydroxybutyric Acid, Attitude to Health, Blood Glucose, Blood Specimen Collection, Home Health Nursing, Lactic Acid and Monitoring, Physiologic.

The authors tagged it with the keywords blood glucose concentrations, ethics, healthy participants, neonate and parent consent.

What This Means in Plain Language

This is an observational study of GLOW Blend (GHK-Cu + BPC-157 + TB-500).

Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2020 (Archives of disease in childhood. Fetal and neonatal edition), a journal based in England.

More context: the GLOW Blend (GHK-Cu + BPC-157 + TB-500) compound page, all human trials.